Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank86
3Y CAGR+26.5%
5Y CAGR+31.4%
Studio
Year-over-Year Change

Free cash flow yield

3Y CAGR
+26.5%/yr
Annual compound
5Y CAGR
+31.4%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
3.9x
Strong expansion
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
20259.68%+1.0%
20249.58%+96.9%
20234.87%+1.7%
20224.79%-24.5%
20216.34%+156.1%
20202.47%+10735.6%
20190.02%+102.4%
2018-0.93%-301.4%
20170.46%-77.5%
20162.06%-